BUB1
protein-codingBUB1 mitotic checkpoint serine/threonine kinase
Gene summary
This gene encodes a serine/threonine-protein kinase that play a central role in mitosis. The encoded protein functions in part by phosphorylating members of the mitotic checkpoint complex and activating the spindle checkpoint. This protein also plays a role in inhibiting the activation of the anaphase promoting complex/cyclosome. This protein may also function in the DNA damage response. Mutations in this gene have been associated with aneuploidy and several forms of cancer. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
- BUB1L
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~40.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005575
Submitter: ClinGen
BUB1 is a mitotic serine-threonine protein kinase that functions with a complex of proteins to support proper chromosomal segregation and kinetochore binding. Loss of function variants in *BUB1* have been implicated in chromosomal segregation errors and aneuploidy. Biallelic *BUB1* mutations are associated with primary microcephaly-30 (MCPH30). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern and phenotypic variability; therefore the autosomal recessive condition has been split and this curation solely focuses on autosomal dominant colorectal cancer. Germline variants in *BUB1* were first reported in humans with colorectal cancer as early as 2013 (de Voer, et al., PMID: 23747338). At least 5 variants (truncating, missense, and splicing variants) identified in 5 individuals with colon cancer from 2 publications were included in this curation (2.7 points, PMID: 23747338, 29448935). These individuals were noted to have polyposis, mosaic aneuploidy, and/or mild dysmorphic features. However, a case-control study (PMID:27713038) found no evidence supporting *BUB1* and hereditary colorectal cancer (scored as contradictory evidence). Experimental evidence was included in this curation (1 point, PMIDs: 9521327, 11283619). Co-immunoprecipitation assay demonstrated that BUB1 interacts with APC. Colorectal cancer cell lines with *BUB1* mutations showed chromosomal instability. In summary, there is limited evidence to support this gene-disease relationship of *BUB1* and autosomal dominant colorectal cancer. This curation was approved by the ClinGen Hereditary Cancer GCEP on 6/23/2023 (SOP Version 9). Summary of Genetic Evidence: 2.7 points; Experimental Evidence: 1 point; Total: 3.7 points.
Inheritance Pattern: AR
Disease ID:MONDO:0859342
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0859342
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0023113
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0859342
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0005575
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0859342
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0000141
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Endocrine; Neurologic
Intervention: Cardiovascular; Endocrine
Rationale: The condition has been described as involving congenital cardiac anomalies, and awareness may allow early diagnosis and management; Growth hormone deficiency has been described, and awareness may allow medical management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BUB1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004336.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 434 | 1 | 441 | ||
| missense | 1 | 938 | 55 | 994 | ||
| nonsense | 2 | 2 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 1 | 5 | 8 | ||
| splice donor/acceptor (+/-2bp) | 2 | 9 | 11 | |||
| Total | 5 | 1 | 961 | 489 | 1 | 1457 |
Highest pathogenic variant AF is 0.000014407482
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004327.1 | 25 | MANE Select | |
| Ensembl | ENSP00000302530.6 | 25 | MANE Select | |
| RefSeq | NP_001265545.1 | 24 | Standard | |
| RefSeq | NP_001265546.1 | 24 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cell cycle - Homo sapiens (human)
- Oocyte meiosis - Homo sapiens (human)
- Progesterone-mediated oocyte maturation - Homo sapiens (human)
- Cell Cycle
- ATM Signaling Network in Development and Disease
Biological Process
- protein phosphorylation
- apoptotic process
- regulation of sister chromatid cohesion
- mitotic cell cycle checkpoint
- mitotic spindle assembly checkpoint
Molecular Function
- protein kinase activity
- protein serine/threonine kinase activity
- protein binding
- ATP binding
Cellular Component
- kinetochore
- condensed chromosome kinetochore
- condensed nuclear chromosome kinetochore
- condensed nuclear chromosome outer kinetochore
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000302759
- Coding exons
- 25
- Length
- 40417
- Individuals with no LoFs
- 125680
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 68
- Defined
- 125748
- p
- 0.000270
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.848 | 500 | 556 | 0.899 | 0.0000267 | 7181 |
| Missense (PolyPhen) | 148 | 190.89 | 0.77531 | 2587 | ||
| Synonymous | 0.444 | 184 | 192 | 0.959 | 0.00000943 | 1958 |
| Loss of Function | 3.98 | 24 | 56.2 | 0.427 | 0.00000248 | 744 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00032 | 0.00032 | rare |
| South Asian | 0.00036 | 0.00036 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase that performs 2 crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Has a key role in the assembly of checkpoint proteins at the kinetochore, being required for the subsequent localization of CENPF, BUB1B, CENPE and MAD2L1. Required for the kinetochore localization of PLK1. Required for centromeric enrichment of AUKRB in prometaphase. Plays an important role in defining SGO1 localization and thereby affects sister chromatid cohesion. Acts as a substrate for anaphase-promoting complex or cyclosome (APC/C) in complex with its activator CDH1 (APC/C-Cdh1). Necessary for ensuring proper chromosome segregation and binding to BUB3 is essential for this function. Can regulate chromosome segregation in a kinetochore-independent manner. Can phosphorylate BUB3. The BUB1-BUB3 complex plays a role in the inhibition of APC/C when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1. Kinase activity is essential for inhibition of APC/CCDC20 and for chromosome alignment but does not play a major role in the spindle-assembly checkpoint activity. Mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:15525512, ECO:0000269|PubMed:15723797, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:17158872, ECO:0000269|PubMed:19487456, ECO:0000269|PubMed:20739936}.;
Recessive Scores
- pRec
- 0.258
Intolerance Scores
- LoFtool
- 0.829
- RVIS EVS
- -1.22
- RVIS percentile EVS
- 5.64
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.832
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |